Skip to main content
icon for Who will Trump announce as next FDA commissioner?

Who will Trump announce as next FDA commissioner?

icon for Who will Trump announce as next FDA commissioner?

Who will Trump announce as next FDA commissioner?

Stephen Hahn 25%

Brett Giroir 16%

Grace Graham 15%

No announcement by December 31 15%

Polymarket
NOWE

Stephen Hahn 25%

Brett Giroir 16%

Grace Graham 15%

No announcement by December 31 15%

Polymarket
NOWE

Kyle Diamantas

$108 Wol.

51%

Stephen Hahn

$90 Wol.

31%

Brett Giroir

$55 Wol.

16%

Grace Graham

$56 Wol.

15%

Sara Brenner

$64 Wol.

7%

No announcement by December 31

$55 Wol.

15%

This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.

This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner.

An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs.

Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner.

Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify.

A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate.

If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”.

The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.
Wolumen
$427
Data zakończenia
Dec 31, 2026
Rynek otwarty
May 12, 2026, 7:59 PM ET
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.

This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner.

An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs.

Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner.

Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify.

A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate.

If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”.

The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.
Wolumen
$427
Data zakończenia
Dec 31, 2026
Rynek otwarty
May 12, 2026, 7:59 PM ET
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.

Uważaj na linki zewnętrzne.

Często zadawane pytania

"Who will Trump announce as next FDA commissioner?" to rynek prognoz na Polymarket z 6 możliwymi wynikami, gdzie traderzy kupują i sprzedają udziały na podstawie tego, co ich zdaniem się wydarzy. Obecny wiodący wynik to "Kyle Diamantas" z 51%, za nim "Stephen Hahn" z 31%. Ceny odzwierciedlają zbiorowe prawdopodobieństwa w czasie rzeczywistym. Na przykład udział wyceniony na 51¢ implikuje, że rynek zbiorowo przypisuje 51% szansy na ten wynik. Te kursy zmieniają się ciągle, gdy traderzy reagują na nowe informacje. Udziały w poprawnym wyniku można wymienić na $1 za sztukę po rozstrzygnięciu rynku.

"Who will Trump announce as next FDA commissioner?" to nowo utworzony rynek na Polymarket, uruchomiony May 13, 2026. Jako wczesny rynek, to Twoja okazja, aby być jednym z pierwszych traderów, którzy ustalą kursy i określą początkowe sygnały cenowe rynku. Możesz też dodać tę stronę do zakładek, aby śledzić wolumen i aktywność handlową w miarę rozwoju rynku.

Aby handlować na "Who will Trump announce as next FDA commissioner?", przeglądaj 6 dostępnych wyników na tej stronie. Każdy wynik wyświetla bieżącą cenę reprezentującą implikowane prawdopodobieństwo rynku. Aby zająć pozycję, wybierz wynik, który uważasz za najbardziej prawdopodobny, wybierz "Tak", aby handlować na jego korzyść, lub "Nie", aby handlować przeciw niemu, wpisz kwotę i kliknij "Handluj". Jeśli wybrany wynik okaże się poprawny, Twoje udziały "Tak" wypłacą $1 za sztukę. Jeśli jest niepoprawny, wypłacą $0. Możesz też sprzedać swoje udziały w dowolnym momencie przed rozstrzygnięciem.

Obecnym faworytem dla "Who will Trump announce as next FDA commissioner?" jest "Kyle Diamantas" z 51%, co oznacza, że rynek przypisuje 51% szansy na ten wynik. Następny najbliższy wynik to "Stephen Hahn" z 31%. Te kursy aktualizują się w czasie rzeczywistym, gdy traderzy kupują i sprzedają udziały, odzwierciedlając najnowszy zbiorowy pogląd na to, co jest najbardziej prawdopodobne. Sprawdzaj regularnie lub dodaj tę stronę do zakładek, aby śledzić zmiany kursów.

Zasady rozstrzygania "Who will Trump announce as next FDA commissioner?" określają dokładnie, co musi się wydarzyć, aby każdy wynik został ogłoszony zwycięzcą — w tym oficjalne źródła danych używane do ustalenia wyniku. Możesz przejrzeć pełne kryteria rozstrzygania w sekcji "Zasady" na tej stronie nad komentarzami. Zalecamy dokładne zapoznanie się z zasadami przed handlem, ponieważ określają one precyzyjne warunki, przypadki graniczne i źródła regulujące rozstrzyganie tego rynku.